UW Bioengineering Professor Dr. Valerie Daggett is hosting December 2014’s UW Walker Ames lecturer, Dr. Michael Levitt, the Robert W. Vivian K. Cahill Professor of Cancer Research in the Department of Structural Biology at Stanford School of Medicine. Dr. Levitt is a 2013 Nobel Laureate in Chemistry and was also Dr. Daggett’s postdoc advisor in the early 1990s.
UW Bioengineering Professor Dr. Valerie Daggett’s research was featured in an article, “Innovative Medicine”, published in the November 2014 issue of Alaska Airlines Magazine. The article discussed novel approaches to treating complex diseases currently being developed by Seattle-area researchers, and details Dr. Daggett’s work designing peptides to neutralize harmful changes to proteins thought to have a role in amyloid diseases like Alzheimer’s.
UW Bioengineering Professor Dr. Valerie Daggett and research team members have designed a peptide structure that can stop harmful changes of proteins in the body that are linked to diseases such as Alzheimer’s, Parkinson’s, heart disease, Type 2 diabetes and Lou Gehrig’s disease (ALS).